DXC vs. RTO, ALLE, FTAI, CART, ULS, MEDP, STN, BILI, HQY, and WPP
Should you be buying DXC Technology stock or one of its competitors? The main competitors of DXC Technology include Rentokil Initial (RTO), Allegion (ALLE), FTAI Aviation (FTAI), Maplebear (CART), UL Solutions (ULS), Medpace (MEDP), Stantec (STN), Bilibili (BILI), HealthEquity (HQY), and WPP (WPP). These companies are all part of the "business services" industry.
DXC Technology vs.
Rentokil Initial (NYSE:RTO) and DXC Technology (NYSE:DXC) are both business services companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, media sentiment, institutional ownership, valuation, community ranking and profitability.
Rentokil Initial has a beta of 1.14, indicating that its share price is 14% more volatile than the S&P 500. Comparatively, DXC Technology has a beta of 1.62, indicating that its share price is 62% more volatile than the S&P 500.
DXC Technology has a consensus price target of $21.29, indicating a potential upside of 24.11%. Given DXC Technology's higher possible upside, analysts clearly believe DXC Technology is more favorable than Rentokil Initial.
DXC Technology received 406 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 61.16% of users gave DXC Technology an outperform vote while only 35.71% of users gave Rentokil Initial an outperform vote.
Rentokil Initial has higher earnings, but lower revenue than DXC Technology. DXC Technology is trading at a lower price-to-earnings ratio than Rentokil Initial, indicating that it is currently the more affordable of the two stocks.
In the previous week, DXC Technology had 7 more articles in the media than Rentokil Initial. MarketBeat recorded 12 mentions for DXC Technology and 5 mentions for Rentokil Initial. Rentokil Initial's average media sentiment score of 1.72 beat DXC Technology's score of 1.03 indicating that Rentokil Initial is being referred to more favorably in the media.
Rentokil Initial has a net margin of 0.00% compared to DXC Technology's net margin of -0.57%. DXC Technology's return on equity of 20.70% beat Rentokil Initial's return on equity.
Rentokil Initial pays an annual dividend of $0.66 per share and has a dividend yield of 2.9%. DXC Technology pays an annual dividend of $0.84 per share and has a dividend yield of 4.9%. Rentokil Initial pays out 43.7% of its earnings in the form of a dividend. DXC Technology pays out -200.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. DXC Technology is clearly the better dividend stock, given its higher yield and lower payout ratio.
9.9% of Rentokil Initial shares are owned by institutional investors. Comparatively, 96.2% of DXC Technology shares are owned by institutional investors. 0.5% of DXC Technology shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
DXC Technology beats Rentokil Initial on 12 of the 21 factors compared between the two stocks.
Get DXC Technology News Delivered to You Automatically
Sign up to receive the latest news and ratings for DXC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
DXC Technology Competitors List
Related Companies and Tools
This page (NYSE:DXC) was last updated on 3/25/2025 by MarketBeat.com Staff